Keywords: Prostate, Prostate, Cancer, Multiparametric MRI, Image quality, the Prostate Imaging Quality Scoring System version 2 (PI-QUAL V2), Prostate Imaging Reporting and Data System (PI-RADS), Diagnostic performance.
Motivation: PI-QUAL V2 was released in May 2024, but its application in clinical practice remains unclear.
Goal(s): To investigate the inter-reader consistency of PI-QUAL V2 and its impact on radiologists' diagnostic confidence and diagnostic performance for csPCa.
Approach: Three radiologists with varying levels of expertise independently assigned PI-QUAL V2 scores to prostate MRI of 581 patients. Inter-observer agreement was evaluated by Kappa statistics. AUC-ROC was employed to evaluate the diagnostic performance for csPCa under various scores.
Results: This study validated its positive role in inter-reader reproducibility and radiologists' MRI diagnosis. However, the value of PI-QUAL V2 in the overall diagnosis of csPCa is limited.
Impact: Undoubtedly, the introduction of PI-QUAL V2 serves as the cornerstone for the widespread application of MRI in prostate clinical practice. However, to constitute an optimal quality assessment framework, it may still require adaptation and fine-tuning.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords